Last updated: September 11, 2024
Sponsor: University of Florida
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
Experimental: Preserving of Donor Lungs
Clinical Study ID
NCT04601818
IRB202001646
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Primary lung transplantation
Informed consent provided
Donor Inclusion: Age<70
Exclusion
Exclusion Criteria:
Re-transplantation
Multi-organ transplantation
Donor exclusion criteria:
Age >70y
Concerns with organ preservation technique
Study Design
Total Participants: 75
Treatment Group(s): 1
Primary Treatment: Experimental: Preserving of Donor Lungs
Phase:
Study Start date:
November 30, 2020
Estimated Completion Date:
September 01, 2025
Connect with a study center
UFHealth Shands
Gainesville, Florida 32601
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.